Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review #MMPMID33107315
Taher M; Miroliaee A; Ebrahimi Daryani N; Alborzi Avanaki F; Aletaha N; Nasiri-Toosi M; Dashti H; Basirat V; Jafarian A
Arch Iran Med 2020[Oct]; 23 (10): 713-717 PMID33107315show ga
The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.